Since ADA (American Diabetes Association) and FDA confirmed that apart from metformin in Type 2 diabetes management, Glucagon-like peptide-1 analogues give favourable results, especially in contraindication and metformin intolerance patients, so the use of GLP-1 agonists is highly preferred treatment in lower serum glucose levels or hypoglycemia
The MHRA has approved specific GLP-1 receptor agonists for weight management (Wegovy and Saxenda) in individuals with a body mass index (BMI) of 30 kg/m or above, or 27 kg/m with weight-related comorbidities, while others are approved only for glycaemic control in type 2 diabetes
Choline chloride modulates learning, memory, and synaptic plasticity impairments in maternally separated adolescent male rats
I feel lighter, more focused, and in control of my appetite
There was no clear indication of the relative benefits of different regimes of vitamin C doses
Woman's World does not endorse the opinions and views shared by our readers in our comment sections